{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T04:05:49Z","timestamp":1749269149222,"version":"3.41.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015220","name":"Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015220","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.clineuro.2023.107928","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T03:31:38Z","timestamp":1691119898000},"page":"107928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Intracranial hematolymphoid malignancies: A case series with molecular characterization"],"prefix":"10.1016","volume":"233","author":[{"given":"Rebekah G.","family":"Langston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Pinckard-Dover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9962-2843","authenticated-orcid":false,"given":"Grace","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher P.","family":"Wardell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5275-1672","authenticated-orcid":false,"given":"Murat","family":"Gokden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"T.W.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.D.","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3426-0508","authenticated-orcid":false,"given":"Analiz","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2023.107928_bib1","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1158\/1078-0432.CCR-11-2019","article-title":"Impact of genomics on personalized cancer medicine","volume":"18","author":"Arteaga","year":"2012","journal-title":"Clin. Cancer Res. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.clineuro.2023.107928_bib2","first-page":"295","article-title":"From the radiologic pathology archives: mass lesions of the dura: beyond meningioma-radiologic-pathologic correlation","volume":"34","author":"Smith","year":"2014","journal-title":"Radio. Rev. Publ. Radio. Soc. N. Am. Inc."},{"key":"10.1016\/j.clineuro.2023.107928_bib3","first-page":"14","article-title":"Thinking about CNS metastasis in cutaneous lymphoma: analysis of existing data","volume":"8","author":"Yang","year":"2017","journal-title":"Leuk. Res. Rep."},{"key":"10.1016\/j.clineuro.2023.107928_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.79","article-title":"Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set","volume":"7","author":"Goyal","year":"2017","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.clineuro.2023.107928_bib5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ajh.24351","article-title":"Central nervous system involvement by multiple myeloma: a multi-institutional retrospective study of 172 patients in daily clinical practice","volume":"91","author":"Jurczyszyn","year":"2016","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.clineuro.2023.107928_bib6","article-title":"Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma","volume":"6","author":"Jethava","year":"2016","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.clineuro.2023.107928_bib7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/cam4.2732","article-title":"An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement","volume":"9","author":"Sunderland","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.clineuro.2023.107928_bib8","first-page":"355","article-title":"Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases","volume":"24","author":"Venkataraman","year":"2011","journal-title":"Mod. Pathol. J. U S Can. Acad. Pathol. Inc."},{"key":"10.1016\/j.clineuro.2023.107928_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.4933","article-title":"Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma","volume":"243","author":"Moody","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.clineuro.2023.107928_bib10","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/nm.3943","article-title":"The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development","volume":"21","author":"Ortega-Molina","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.clineuro.2023.107928_bib11","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2021.12659","article-title":"Role of FAT1 in health and disease","volume":"21","author":"Peng","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.clineuro.2023.107928_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/2193-1801-3-29","article-title":"Central nervous system involvement in mycosis fungoides: relevance of tcr gene testing in cerebrospinal fluid","volume":"3","author":"Giorli","year":"2014","journal-title":"SpringerPlus"},{"key":"10.1016\/j.clineuro.2023.107928_bib13","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.clml.2013.09.016","article-title":"Central nervous system involvement in cutaneous T-cell lymphoma: 2 illustrative cases and a review of current literature","volume":"14","author":"Zhao","year":"2014","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.clineuro.2023.107928_bib14","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.4161\/cc.24662","article-title":"Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma","volume":"12","author":"Liu","year":"2013","journal-title":"Cell Cycle Georg. Tex."},{"key":"10.1016\/j.clineuro.2023.107928_bib15","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1073\/pnas.1303607110","article-title":"TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal","volume":"110","author":"Killela","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clineuro.2023.107928_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.gde.2020.02.001","article-title":"TERT promoter mutations and telomeres during tumorigenesis","volume":"60","author":"Lorbeer","year":"2020","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.clineuro.2023.107928_bib17","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1002\/cam4.4200","article-title":"Expression of telomerase reverse transcriptase in peripheral T-cell lymphoma","volume":"10","author":"Arakawa","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.clineuro.2023.107928_bib18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ajh.24324","article-title":"Acquired TERT promoter mutations stimulate TERT transcription in mantle cell lymphoma","volume":"91","author":"Panero","year":"2016","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.clineuro.2023.107928_bib19","article-title":"TERT promoter mutation associated with multifocal phenotype and poor prognosis in patients with IDH wild-type glioblastoma","volume":"2","author":"Kikuchi","year":"2020","journal-title":"Neuro-Oncol. Adv."},{"key":"10.1016\/j.clineuro.2023.107928_bib20","doi-asserted-by":"crossref","first-page":"23822","DOI":"10.18632\/aging.104030","article-title":"Calreticulin increases growth and progression of natural killer\/T-cell lymphoma","volume":"12","author":"Zheng","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.clineuro.2023.107928_bib21","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1182\/blood-2009-12-260216","article-title":"Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma","volume":"116","author":"Kamstrup","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clineuro.2023.107928_bib22","article-title":"Clinical characteristics, treatment, and prognosis of 118 cases of myeloid sarcoma","volume":"12","author":"Zhao","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clineuro.2023.107928_bib23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.5414\/NP300949","article-title":"Central nervous system involvement by myeloid sarcoma: a report of 12 cases and review of the literature","volume":"35","author":"Olar","year":"2016","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.clineuro.2023.107928_bib24","first-page":"333","article-title":"Myeloid sarcoma with CBFB-MYH11 fusion (inv(16) or t(16;16))","volume":"153","author":"Dalland","year":"2020","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.clineuro.2023.107928_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/13776","article-title":"The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia","volume":"23","author":"Castilla","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clineuro.2023.107928_bib26","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clineuro.2023.107928_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-021-00503-6","article-title":"Core binding factor acute myelogenous leukemia-2021 treatment algorithm","volume":"11","author":"Borthakur","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.clineuro.2023.107928_bib28","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1080\/17474086.2019.1657400","article-title":"Trisomy 8 in acute myeloid leukemia","volume":"12","author":"Hemsing","year":"2019","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.clineuro.2023.107928_bib29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.clml.2013.04.012","article-title":"Thoracic t(9;22)-positive granulocytic sarcoma as initial presentation of chronic myeloid leukemia","volume":"13","author":"Mitchell","year":"2013","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.clineuro.2023.107928_bib30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/cancers9040029","article-title":"The role of PI3K isoforms in regulating bone marrow microenvironment signaling focusing on acute myeloid leukemia and multiple myeloma","volume":"9","author":"Piddock","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.clineuro.2023.107928_bib31","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.3390\/ijms22073464","article-title":"PI3K inhibitors in cancer: clinical implications and adverse effects","volume":"22","author":"Mishra","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clineuro.2023.107928_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-022-00643-3","article-title":"Extramedullary disease in multiple myeloma: a systematic literature review","volume":"12","author":"Blad\u00e9","year":"2022","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.clineuro.2023.107928_bib33","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.clml.2014.12.013","article-title":"Features of extramedullary disease of multiple myeloma: high frequency of p53 deletion and poor survival: a retrospective single-center study of 834 cases","volume":"15","author":"Deng","year":"2015","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.clineuro.2023.107928_bib34","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2141.2004.05199.x","article-title":"Multiple myeloma involving central nervous system: high frequency of chromosome 17p13.1 (p53) deletions","volume":"127","author":"Chang","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clineuro.2023.107928_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2141.2002.03401.x","article-title":"Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations","volume":"117","author":"Fassas","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clineuro.2023.107928_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/bjh.12223","article-title":"Cytogenetics of extramedullary manifestations in multiple myeloma","volume":"161","author":"Billecke","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clineuro.2023.107928_bib37","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1182\/blood-2018-03-840132","article-title":"Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma","volume":"132","author":"Walker","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clineuro.2023.107928_bib38","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.3390\/cancers13235949","article-title":"Genome instability in multiple myeloma: facts and factors","volume":"13","author":"Aksenova","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.clineuro.2023.107928_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.704471","article-title":"PHF6 mutations in hematologic malignancies","volume":"11","author":"Kurzer","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.clineuro.2023.107928_bib40","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","article-title":"Mutation in TET2 in myeloid cancers","volume":"360","author":"Delhommeau","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2023.107928_bib41","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1038\/leu.2008.142","article-title":"Clinical and biological significance of RAS mutations in multiple myeloma","volume":"22","author":"Chng","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.clineuro.2023.107928_bib42","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1182\/bloodadvances.2020002953","article-title":"Human GATA2 mutations and hematologic disease: how many paths to pathogenesis?","volume":"4","author":"Bresnick","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.clineuro.2023.107928_bib43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-018-0589-1","article-title":"Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1\/PD-L1 pathway","volume":"11","author":"Tremblay-LeMay","year":"2018","journal-title":"J. Hematol. Oncol. J. Hematol. Oncol."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030384672300344X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030384672300344X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T14:28:27Z","timestamp":1749220107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030384672300344X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":43,"alternative-id":["S030384672300344X"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2023.107928","relation":{},"ISSN":["0303-8467"],"issn-type":[{"type":"print","value":"0303-8467"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracranial hematolymphoid malignancies: A case series with molecular characterization","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2023.107928","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107928"}}